INNOVATE BIOPHARMACEUTICLS I's ticker is INNT and the CUSIP is 45782F105. A total of 37 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q2 2018. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $2,000 | -83.3% | 3,173 | -86.1% | 0.00% | – |
| Q4 2019 | $12,000 | +200.0% | 22,760 | +502.9% | 0.00% | – |
| Q3 2019 | $4,000 | -20.0% | 3,775 | -29.1% | 0.00% | – |
| Q2 2019 | $5,000 | -89.8% | 5,322 | -79.9% | 0.00% | – |
| Q1 2019 | $49,000 | -16.9% | 26,516 | +1.0% | 0.00% | – |
| Q4 2018 | $59,000 | -89.1% | 26,244 | -66.9% | 0.00% | – |
| Q3 2018 | $540,000 | -65.7% | 79,175 | +18.4% | 0.00% | – |
| Q2 2018 | $1,574,000 | +69.8% | 66,873 | +97.4% | 0.00% | – |
| Q1 2018 | $927,000 | – | 33,880 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,336,248 | $1,550,000 | 1.95% |
| Hillview Capital Advisors, LLC | 19,610 | $23,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 64,786 | $75,000 | 0.01% |
| Virtu Financial LLC | 62,822 | $73,000 | 0.00% |
| BREWIN DOLPHIN LTD | 25,000 | $29,000 | 0.00% |
| Paloma Partners Management Co | 89,694 | $104,000 | 0.00% |
| JANE STREET GROUP, LLC | 12,923 | $15,000 | 0.00% |
| UBS Group AG | 61 | $0 | 0.00% |
| BARCLAYS PLC | 240 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 337 | $0 | 0.00% |